Page 47 - 《中国药科大学学报》2025年第4期

第 56 卷第 4 期 乔振宇，等：调控转录因子 GLI1 与 DNA 相互作用的药物研发策略 443

2018, 33(1): 349-358. [49] Maresca L, Crivaro E, Migliorini F, et al. Targeting GLI1 and
[42] Bosco-Clément G, Zhang F, Chen Z, et al. Targeting Gli tran- GLI2 with small molecule inhibitors to suppress GLI-depen-
scription activation by small molecule suppresses tumor dent transcription and tumor growth[J]. Pharmacol Res, 2023,
growth[J]. Oncogene, 2014, 33(16): 2087-2097. 195: 106858.
[43] Beauchamp EM, Ringer L, Bulut G, et al. Arsenic trioxide in- [50] Hosoya T, Arai MA, Koyano T, et al. Naturally occurring
hibits human cancer cell growth and tumor development in mice small-molecule inhibitors of hedgehog/GLI-mediated transcrip-
by blocking Hedgehog/GLI pathway[J]. J Clin Invest, 2011, tion[J]. Chembiochem, 2008, 9(7): 1082-1092.
121(1): 148-160.
[51] Zhu XY, Ye ST, Yu DK, et al. Physalin B attenuates liver fibro-
[44] Infante P, Mori M, Alfonsi R, et al. Gli1/DNA interaction is a
sis via suppressing LAP2α-HDAC1-mediated deacetylation of
druggable target for Hedgehog-dependent tumors[J]. EMBO J,
the transcription factor GLI1 and hepatic stellate cell
2015, 34(2): 200-217.
activation[J]. Br J Pharmacol, 2021, 178(17): 3428-3447.
[45] Chen J, Ma D, Zeng CC, et al. Solasodine suppress MCF7
[52] Hinterndorfer M, Spiteri VA, Ciulli A, et al. Targeted protein
breast cancer stem-like cells via targeting Hedgehog/Gli1[J].
degradation for cancer therapy[J]. Nat Rev Cancer, 2025, 25(7):
Phytomedicine, 2022, 107: 154448.
493-516.
[46] Abu Rabe D, Chdid L, Lamson DR, et al. Identification of nov-
[53] Agyeman A, Jha BK, Mazumdar T, et al. Mode and specificity
el GANT61 analogs with activity in hedgehog functional assays
of binding of the small molecule GANT61 to GLI determines
and GLI1-dependent cancer cells[J]. Molecules, 2024, 29(13):
inhibition of GLI-DNA binding[J]. Oncotarget, 2014, 5(12):
3095.
4492-4503.
[47] Dash RC, Wen JC, Zaino AM, et al. Structure-based virtual
screening identifies an 8-hydroxyquinoline as a small molecule [54] Li XY, Sun R, Wu H, et al. Targeting the Hedgehog pathway
GLI1 inhibitor[J]. Mol Ther Oncolytics, 2021, 20: 265-276. with novel Gli1 hydrophobic tagging degraders[J]. Bioorg
[48] Manetti F, Maresca L, Crivaro E, et al. Quinolines and oxazino- Chem, 2023, 138: 106649.
quinoline derivatives as small molecule GLI1 inhibitors identi- [55] Xie X, Yu TT, Li X, et al. Recent advances in targeting the
fied by virtual screening[J]. ACS Med Chem Lett, 2022, 13(8): “undruggable” proteins: from drug discovery to clinical
1329-1336. trials[J]. Signal Transduct Target Ther, 2023, 8(1): 335.

专家介绍］陆朦辰，苏州大学副教授，主要研究方向为靶向泛素
［ E3 连接酶和转录因子家族的药
物化学生物学研究及抗肿瘤创新药物的研发工作。主持国家自然科学基金面上项目 1 项、国家自
然科学基金青年项目 1 项、中国博士后基金 2 项，市厅级项目 2 项。相关工作以第一或通信作者
发表在学科权威杂志 Med Res Rev，Cell Chem Biol, J Med Chem，Redox Biol，Euro J Med
Chem，申请专利 10 余项，授权专利 5+项。苏州大学优秀青年学者，姑苏“双创领军人才”，
Molecules 期刊客座编辑，《中国药科大学学报》、《中国药物化学杂志》青年编委。